Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
It’s sweet victory for Brown Suga; KC’s favorite cookie crew wins AltCap Your Biz (and a $25K treat)
After winning the $25,000 grand prize at Wednesday’s AltCap Your Biz pitch competition, Brown Suga will get some cookie-shaped new wheels, shared founder Ebony Paul. Before opening a brick-and-mortar in Olathe, the cookie bakery launched in 2020 selling at pop-ups and community events. Adding a food truck will help Brown Suga continue to hit the…
World Cup is sprinting closer; entrepreneurs should be preparing now, say regional biz leaders
Kansas City is kicking plans into high gear as the 2026 FIFA World Cup heads to the pitch — with local leaders eager to capitalize on the massive economic impact expected from the once-in-a-lifetime opportunity. “The 2026 World Cup will be the largest event mankind has ever put on, and it’s going to be the…
Just funded: LaunchKC unveils 7 newest grant winners, topping $385K in startup capital
LaunchKC’s big reveal Tuesday was about more than checking a box — or getting hands on oversized checks — with grant competition winners taking the stage to introduce their companies to an eager community of supporters, entrepreneurs and investors. “This event is incredible,” said Donnie Hampton, co-founder of Roz, one of seven startups honored Tuesday…
This founder’s own pain point became too painful; Why he’s back to embracing the loss that sparked his startup
When healthtech founder Chris Jones pivoted away from the painful memory of losing his son — a catalyst for launching his medical records startup — he shelved a vital piece of the “why” behind both his company and his passion, Jones said. “I never understood what my power was — not just the technology —…